Literature DB >> 3366919

Hodgkin's disease: a flow cytometric study.

K G Morgan1, P Quirke, C J O'Brien, C C Bird.   

Abstract

Flow cytometry was performed on paraffin embedded tissue from 115 cases of Hodgkin's disease. Thirteen (11%) tumours were aneuploid with no significant difference between the histological subgroups. The median proliferative index was 14%, and the highest values were found in the NS2 (16.4%) and lymphocyte depleted (16.0%) subgroups. The difference in proliferative index approached significance when the NS2 subgroup was compared with the NS1 subgroup (p less than or equal to 0.11) and when the lymphocyte depleted and NS2 subgroups combined were compared with the mixed cellularity, lymphocyte predominance, and NS1 subgroups combined (p less than or equal to 0.07). There was a trend towards better survival for patients with aneuploid tumours and those cases with a proliferative index below 15%, but neither of these trends was significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366919      PMCID: PMC1141457          DOI: 10.1136/jcp.41.4.365

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Hodgkin's disease. A clinical and pathologic study of 235 cases.

Authors:  A S Patchefsky; H Brodovsky; M Southard; H Menduke; S Gray; W S Hoch
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

2.  Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition.

Authors:  L W Coppleson; H Rappaport; S B Strum; J Rose
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

3.  A clinicopathological study of nodular sclerosing Hodgkin's disease.

Authors:  R M Cross
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

4.  Correlation of histopathology with other prognostic indicators in Hodgkin's disease.

Authors:  A R Keller; H S Kaplan; R J Lukes; H Rappaport
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

5.  Establishment and characterization of a cloned giant cell line from a patient with Hodgkin's disease.

Authors:  L Olsson; O Behnke; N Pleibel; F D'Amore; O Werdelin; K E Fry; H S Kaplan
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

6.  The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Authors:  S E Shackney; A M Levine; R I Fisher; P Nichols; E Jaffe; W H Schuette; R Simon; C A Smith; S J Occhipinti; J W Parker
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 7.  Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.

Authors:  R J Lukes
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

8.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

9.  Hodgkin's cell lines: characteristics and possible pathogenetic implications.

Authors:  V Diehl; H Burrichter; M Schaadt; H H Kirchner; C Fonatsch; H Stein; J Gerdes; W Heit; A Ziegler
Journal:  Hematol Oncol       Date:  1983 Apr-Jun       Impact factor: 5.271

10.  Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology.

Authors:  W Hiddemann; J Schumann; M Andreef; B Barlogie; C J Herman; R C Leif; B H Mayall; R F Murphy; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1984-10
View more
  4 in total

Review 1.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

2.  Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.

Authors:  L Leoncini; M T Del Vecchio; R Kraft; T Megha; P Barbini; G Cevenini; S Poggi; S Pileri; P Tosi; H Cottier
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

4.  Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.

Authors:  J Freeman; D B Kellock; C C Yu; J Crocker; D A Levison; P A Hall
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.